Regulation of adipolin/CTRP12 cleavage by obesity

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 155-159

  Enomoto, Takashi ^a   Shibata, Rei ^a   Ohashi, Koji ^a   Kambara, Takahiro ^a   Kataoka, Yoshiyuki ^a   Uemura, Yusuke ^a   Yuasa, Daisuke ^a   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipolin; CTRP; Furin; Obesity; Proprotein convertase; TNF

Indexed keywords

ADIPOCYTOKINE; ADIPOLIN; FURIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

3T3-L1 CELLS; ADIPOKINES; ADIPOSE TISSUE; AMINO ACID MOTIFS; ANIMALS; DIET; FURIN; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; OBESITY; PROPROTEIN CONVERTASES; SEQUENCE DELETION; THINNESS; UP-REGULATION;

MUS;

EID: 84868352260     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.031     Document Type: Article

References (26)

1. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:35-42.
2. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
3. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
4. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
5. Spiegelman B.M., Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389.
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
7. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
8. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
9. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., Funahashi T., Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 2004, 279:1304-1309.
10. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
11. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., Funahashi T., Ouchi N., Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
12. Wong G.W., Wang J., Hug C., Tsao T.S., Lodish H.F. A family of Acrp30/adiponectin structural and functional paralogs. Proc. Natl. Acad. Sci. USA 2004, 101:10302-10307.
13. Ouchi N., Walsh K. Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins. Circulation 2012, 125:3066-3068.
14. Kambara T., Ohashi K., Shibata R., Ogura Y., Maruyama S., Enomoto T., Uemura Y., Shimizu Y., Yuasa D., Matsuo K., Miyabe M., Kataoka Y., Murohara T., Ouchi N. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J. Biol. Chem. 2012, 287:18965-18973.
15. Y. Uemura, R. Shibata, K. Ohashi, T. Enomoto, T. Kambara, T. Yamamoto, Y. Ogura, D. Yuasa, Y. Joki, K. Matsuo, M. Miyabe, Y. Kataoka, T. Murohara, N. Ouchi, Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation, FASEB J. (in press).
16. Enomoto T., Ohashi K., Shibata R., Higuchi A., Maruyama S., Izumiya Y., Walsh K., Murohara T., Ouchi N. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J. Biol. Chem. 2011, 286:34552-34558.
17. Wei Z., Peterson J.M., Lei X., Cebotaru L., Wolfgang M.J., Baldeviano G.C., Wong G.W. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J. Biol. Chem. 2012, 287:10301-10315.
18. Ke S.H., Madison E.L. Rapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method. Nucleic Acids Res. 1997, 25:3371-3372.
19. Duckert P., Brunak S., Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 2004, 17:107-112.
20. Croissandeau G., Basak A., Seidah N.G., Chrétien M., Mbikay M. Proprotein convertases are important mediators of the adipocyte differentiation of mouse 3T3-L1 cells. J. Cell Sci. 2002, 115:1203-1211.
21. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118:2992-3002.
22. Gregor M.G., Hotamisligil G.S. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res. 2007.
23. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
24. Z. Wei, X. Lei, M. Seldin, G.W. Wong, Endopeptidase cleavage generates a functionally distinct isoform of CTRP12 with an altered oligomeric state and signaling specificity, J. Biol. Chem. (in press).
25. Schlöndorff J B.J., Blobel C.P. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 2000, 138:131-138.
26. Adrain C., Zettl M., Christova Y., Taylor N., Freeman M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 2012, 335:225-228.